Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
about
P1343
Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2Sumoylation pathway is required to maintain the basal breast cancer subtypeTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineIn vitro comparative models for canine and human breast cancersCancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer MedicineTumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsNuclear transport of galectin-3 and its therapeutic implicationsResistance to inhibitors of cholinesterase (Ric)-8A and Gαi contribute to cytokinesis abscission by controlling vacuolar protein-sorting (Vps)34 activityMatch criteria for human cell line authentication: where do we draw the line?Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stressBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistEvidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model systemBreast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibitionDo breast cancer cell lines provide a relevant model of the patient tumor methylome?A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidasemiR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcomeCytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.A community effort to assess and improve drug sensitivity prediction algorithms.Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signalingEvidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiencyFunctional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.sCNAphase: using haplotype resolved read depth to genotype somatic copy number alterations from low cellularity aneuploid tumors.Breast cancer diagnosis using a microfluidic multiplexed immunohistochemistry platform.Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cellsTumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response.Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype.Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmPatterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells.Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen speciesSimvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
P2860
Q16880225-56EF1227-B7CA-452C-A19C-FFFBBE06B113Q17577870-5BA48A80-761D-4503-8FD8-D214A0485E8CQ1881253-F1B6DE0B-949E-4298-968E-A5D610227406Q28872477-287E447F-5915-4F10-9F04-0072903EB211Q52392673-6A7F625F-D086-4716-B0C5-0C3206AD667EQ54582476-854664B3-BC02-4C88-B1EB-5F11E17F036EQ54798460-D28899E8-8502-4483-8E1D-00F2D310F327Q54798468-1E748EA3-BEB0-4397-B2E5-0B85A02D5EA1Q54798471-F97E2C08-692B-42AF-9A07-52C3E0FCFF83Q54808406-9CB3887B-EA7A-43A2-8B9C-4573F19053A7Q54832051-E9104D64-C3C3-4D13-A81C-889D6A681A33Q54832052-06EC010A-3748-4964-B662-4F406D6DA03CQ54881517-D86072E8-0AAF-4DB5-8B63-EA2874C3B509Q54881530-E552CA98-BC3D-4B0C-B6FE-3B5589FBD906Q54881536-BF695E4F-B939-4436-BF1E-A7859EB82436Q54881565-0433EE22-09D8-42F7-BC0E-79180125711BQ54881567-E8C26831-A489-430F-9144-4F89A5516138Q54881570-4C1DE2DB-39DB-4FBD-A5C9-A904E0BFAC88Q54881583-B3B51C9B-BAB6-4F0E-ACD5-D4DFD8DADEC1Q54881587-D49D6106-0D30-4D3F-BED2-D9C707AF81B0Q54881591-D0FEF4F5-A946-4DD9-8EC0-0EE8DE528558Q54881605-3BD922FF-177C-4E05-B5B8-B44C5423B408Q54881618-7DB1BCC9-7E7A-46B7-8B95-6397F0B9108CQ54881628-D48067FC-A9B2-4377-BB97-5D51A2B5EEC2Q54881634-BB4F0A98-2DCB-4BA0-834E-5DC57D0526B6Q54881636-4AB40710-3815-421F-98F7-5D5784150C5AQ54881637-0B2B2A65-2F1B-46D8-A8A3-DF55B536883FQ54881664-A945F059-3AD1-4737-A0EE-AE30E446BAF4Q54881686-54788A53-1EBE-49A9-8B6D-777635690F8AQ54881712-6C7CE3FB-ABAC-4719-B159-6A5E6D0FB62DQ54881772-906FC449-7ACC-433C-9572-BDEEC96E5393Q54881774-EC4B8FB6-FB08-437A-B42B-DC02A1C381ACQ54895774-CEEE2FAA-7AB7-48B8-B7FB-78EBFE164EECQ54896623-ABE6CAF2-C67D-4CC7-9A19-CD726C22E1E9Q54904280-744A628D-5246-40B1-89AC-BB6AFDE316AAQ54904577-3C7B5393-F0D8-48B2-8153-18381F624B66Q54904578-20FF5187-A33F-4074-B14B-DB3DBA4DFD53Q54904579-BA5ABE10-38D6-48EF-AD6F-C4E97F16DCC1Q54904626-F7DE8C96-F7C1-4D67-B5C8-78CEB501C5BFQ54904639-DC557C41-D366-4479-913A-DDACD9905BFF
P1343
Q21134904-D31B14DD-D2F8-4C77-8CA9-C3FEDCA782B6Q24297866-B0F7995A-4C3B-4066-917A-CD6BBB04C744Q24630783-9C86C43D-6FD5-42ED-956B-1DE1C652B15BQ24633907-A78A7715-E98A-4DB8-92C4-3C6F4883F527Q26748603-D0A323CB-2AEC-4D59-AB04-EB8D15EB2A38Q26752714-FA310638-105A-462E-8852-9F53404F2F70Q26800337-E34E10DF-6FA8-41AF-866A-41735485037CQ26801410-64CCE912-0300-4CDE-8426-E942CCD514D6Q26824889-081B7DE0-1049-48F0-A5E2-2845F49D4C4AQ27329917-BE3A5D50-F869-45DF-A533-A7289E247C3FQ27910530-92C7C022-3C98-47E5-84A9-878D725EAD68Q28389612-C5CB9573-D56C-4818-BB22-16E539B0F451Q28475994-9A7E98CF-BD2A-4D60-AC91-CA1911988F49Q28484040-32AE7E1C-757E-4D8A-BB3C-6D1C2C542F60Q28534478-BC517DE2-F250-4ACA-8141-4A13DB0020E9Q28542556-CEDA47F7-B94C-4F7F-BB14-81912564C61CQ29871434-180ED9B0-5E40-4AE1-BB85-33C60612852EQ30313534-A1E10BE5-B8B2-4F3E-B123-C450F8F61F44Q30352693-5D60D058-57E8-4BA8-967E-3949A5355700Q30371323-672EAD91-6605-4EF1-883B-0FCF1FB2887CQ30500481-594D9BAB-0496-49E8-9D57-2D00B2F0C8A6Q31132241-419E4A62-1AEF-4EC7-931A-CD1AFB3ED1B8Q33544002-747C50B4-4D36-4793-BE8E-3D39010D47AAQ33556895-728111BA-4507-4540-83C1-D15DD7464FC6Q33558237-E5417B92-60E1-4D6C-9617-22ED09440BABQ33573511-9B327BAE-3C36-45F1-BBC1-DA4E573F456EQ33604560-DDDFB707-5717-425B-BD5F-3F8061543416Q33628528-F7EC800D-DEFB-46C6-8B5E-FC1E2ACEBC94Q33665716-06D5C5B5-AC1A-4171-921A-575A98C56702Q33668653-FFF2A3E6-A905-4000-B42E-2174D13A7F17Q33688623-D5EF96A3-28BC-476D-AECF-8DA20BD28D28Q33722847-1B11BDC2-1441-4BD5-8553-A4BE214744FFQ33731278-EBD04AEF-0891-4A31-AAC9-E5FB11F21D9CQ33731365-72F6D844-BC61-44C8-9444-6579EF14DF97Q33739941-FC63F5DD-DBB4-4296-B9F6-038E16437744Q33741864-8A904ECA-BCDB-4540-BD00-F661DB715D74Q33757096-EA8EE389-671B-4F8F-91F9-7BBCC8CFF7F4Q33763213-3A43BEB5-D2F2-4106-B0D6-6AEF3297AACFQ33781991-35C67990-6FE4-4725-BDDD-14E12C8A5AC9Q33816245-C5D3C7D7-FB55-4864-844D-EB211330FBCD
P2860
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Molecular profiling of breast ...... rce for cancer gene discovery.
@ast
Molecular profiling of breast ...... rce for cancer gene discovery.
@en
type
label
Molecular profiling of breast ...... rce for cancer gene discovery.
@ast
Molecular profiling of breast ...... rce for cancer gene discovery.
@en
prefLabel
Molecular profiling of breast ...... rce for cancer gene discovery.
@ast
Molecular profiling of breast ...... rce for cancer gene discovery.
@en
P2093
P2860
P4510
P1433
P1476
Molecular profiling of breast ...... rce for cancer gene discovery.
@en
P2093
Adi F Gazdar
Jeet Gandhi
Jessica Kao
John D Minna
Kevin A Kwei
Luc Girard
Melanie Bocanegra
Tina Hernandez-Boussard
Yoon-La Choi
P2860
P356
10.1371/JOURNAL.PONE.0006146
P407
P577
2009-07-03T00:00:00Z